Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
MedTech

Dublin's Akara Raises US$5.5m to Expand Hospital AI Sensors

Sreepriya Prasannan
Sreepriya Prasannan

NewsWritten by our team from the primary sources linked below. Reviewed, verified and approved by a human editor. How we check

Speed:
Dublin's Akara Raises US$5.5m to Expand Hospital AI Sensors

Akara, a Dublin health-tech company spun out of Trinity College Dublin, has raised US$5.5 million in venture funding led by Locke Health, it announced on 11 November 2026. The round takes Akara's total funding to US$12.3 million. The money will expand its Irish engineering and operations teams and grow its hospital AI.

Akara makes wall-mounted thermal sensors with on-device AI that record how clinical rooms are used, without capturing detailed images of patients or staff. The company says the technology is already deployed in hospitals in Ireland, the UK and the US, but it has not named any of them.

Key Highlights:
  • Round: US$5.5 million in venture funding, announced 11 November 2026; total raised to date US$12.3 million.
  • Lead investor: Locke Health. New investors VTC Ventures, the EIC Fund, CommonKind and NovaVector Holdings joined.
  • Existing backers: ACT, Atlantic Bridge and Enterprise Ireland, plus unnamed strategic angel investors.
  • Use of funds: faster hospital adoption, larger operations and engineering teams in Ireland, and AI agents for more healthcare uses.
  • Not disclosed: valuation, headcount, hiring numbers and the names of hospitals using the system.

Who invested in Akara's round?

The investor list is the same in Akara's GlobeNewswire release, Trinity College Dublin's announcement and Silicon Republic's report. The round size implies that Akara had raised about US$6.8 million before this round (US$12.3 million minus US$5.5 million); the company did not give a breakdown of earlier rounds.

Investors in Akara's US$5.5 million round, as named by Akara and Trinity College Dublin
InvestorRole in the round
Locke HealthLead investor
VTC VenturesNew investor
EIC Fund (European Innovation Council)New investor
CommonKindNew investor
NovaVector HoldingsNew investor
ACT, Atlantic Bridge, Enterprise IrelandExisting investors
Strategic angel investorsParticipated; names and number not disclosed
Individual amounts and valuationNot disclosed

Patrick Brennan, Managing Director of Locke Health, told Silicon Republic that "Akara stands out for its potential to deliver a compelling return on investment" without heavy demands on hospital budgets, infrastructure or staff. James Ramey, Managing Director of VTC Ventures, said in Akara's release: "What excites us about Akara is the connection between understanding hospital activity and acting on it."

What does Akara's hospital technology do?

Akara's release says camera-based ways of tracking hospital rooms raise privacy concerns and need costly infrastructure upgrades. Its answer is a thermal sensor mounted on the wall that processes data on the device itself (edge AI). The company's website puts it as: "Sees every room, never who's in it."

Akara's products, as described on akara.ai and in the 11 November release
ProductWhat the company says it does
Akara AI SensorWall-mounted thermal sensor that captures room activity and use; software detects key events and alerts staff
Cara AIAI assistant that answers natural-language questions about room availability and use, and generates reports
Akara RobotUV-C disinfection robot

The release says the system is in use in US ambulatory surgery centres and hospitals. Akara's website describes customers only in anonymised terms, such as a leading US surgery centre, rather than naming them. Earlier, in December 2024, Trinity reported that Akara had deployed two UV decontamination robots at Friarage Hospital in Northallerton, part of South Tees Hospitals NHS Foundation Trust, to speed up room turnaround in wards and operating theatres. The website also lists HIPAA, SOC 2 Type 2, ISO 27001, CE/UKCA, NHS Cyber Essentials and FCC under its compliance credentials.

Who is behind Akara?

Silicon Republic reports that Akara was founded in 2020. Trinity names the founders as Dr Conor McGinn, Cian Donovan, Niamh Donnelly, Michael Cullinan and Eamon Bourke. McGinn is co-founder and CEO, and an assistant professor in Trinity's School of Engineering; Donnelly is CTO. The founders previously built Stevie, a social robot that appeared on the cover of TIME in 2019. In October 2025 TIME named the Akara AI Sensor one of its Best Inventions of 2025, and in September 2025 Akara won the Irish leg of KPMG's Global Tech Innovator competition.

McGinn said, in Trinity's announcement: "Hospitals are under enormous pressure to do more with the people and resources they already have."

What does the funding mean for Ireland?

Akara's Irish office is at The Digital Court, Rainsford Street, Dublin 8, and it also has an office in Culver City, California, according to its website. The release says it has offices in Ireland, Los Angeles and the UK. The new money is earmarked in part for expanding operations and engineering teams in Ireland, but no job numbers were given. Enterprise Ireland, the State's enterprise agency, is an existing investor, and Akara's website lists backing from the European Innovation Council's EIC Accelerator.

The deal adds to recent Irish health AI funding, such as the Neurobell neonatal seizure monitor round in Cork and PulseAI's FDA clearance in Belfast. Readers tracking Irish medtech can use our medical devices register and Who's Hiring in Ireland page.

Frequently asked questions

How much has Akara raised?

US$5.5 million in this round, announced on 11 November 2026, for a total of US$12.3 million to date.

Who led Akara's funding round?

Locke Health led the round, with VTC Ventures, the EIC Fund, CommonKind and NovaVector Holdings joining, and existing investors ACT, Atlantic Bridge and Enterprise Ireland taking part.

Does Akara use cameras in hospitals?

No. The company says its wall-mounted sensors use thermal sensing with on-device AI and do not record detailed images of patients or staff.

Which Irish hospitals use Akara?

Not disclosed. Akara says its technology is deployed in hospitals in Ireland, the UK and the US but has not named the Irish sites.

Is Akara hiring in Ireland?

The company says it will expand its operations and engineering teams in Ireland. It has not published a number of roles.

Outlook

Akara's stated next steps are wider hospital adoption, a larger Irish team and AI agents for more healthcare uses. The release gave no timeline or customer targets. Priya Life Science will report named hospital deployments, especially any in the Irish health service, and hiring numbers when Akara publishes them.

Sources

Cover image: an empty operating theatre at Ipswich Hospital, Queensland, Australia, in 2022. It is not an Akara customer site and does not show Akara equipment. Photo: Kgbo, CC BY-SA 4.0, via Wikimedia Commons, cropped.

Reviewed for editorial accuracy by Sreepriya Prasannan, Founder & Editor MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany
Our standards
Most-trialled drugs in our registers
Browse all trial registers →

Get the Friday brief

One email every Friday: a 60-second summary, then only the topics you choose: industry news, approvals and market access, shortages, Irish trials, careers or data, all built from public registers.

Free. Unsubscribe from any email with one click. See our privacy policy.

About the Author
Sreepriya Prasannan

Sreepriya Prasannan

Writer at Priya Life Science · MedTech

Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.

Discussion
No comments yet. Be the first to share your thoughts!
Leave a Comment